Middle East and Africa Clinical Trials Supplies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East and Africa Clinical Trials Supplies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa Clinical Trials Supplies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East and Africa Clinical Trials Supplies Market Regional Analysis

6.2 Middle East and Africa Clinical Trials Supplies Market Revenue 2017-2027 (US$ Million)

6.3 Middle East and Africa Clinical Trials Supplies Market Forecast Analysis

7. Middle East and Africa Clinical Trials Supplies Market Analysis – by Product & Service

7.1 Manufacturing

7.1.1 Overview
7.1.2 Manufacturing: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Packaging & Labelling

7.2.1 Overview
7.2.2 Packaging & Labelling: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Logistics & Distribution

7.3.1 Overview
7.3.2 Logistics & Distribution: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Middle East and Africa Clinical Trials Supplies Market Analysis – by Stage

8.1 Phase I

8.1.1 Overview
8.1.2 Phase I: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Phase II

8.2.1 Overview
8.2.2 Phase II: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Phase III

8.3.1 Overview
8.3.2 Phase III: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Bioequivalence Studies

8.4.1 Overview
8.4.2 Bioequivalence Studies: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Middle East and Africa Clinical Trials Supplies Market Analysis – by Drug Type

9.1 Small-Molecule Drugs

9.1.1 Overview
9.1.2 Small-Molecule Drugs: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Biologic Drugs

9.2.1 Overview
9.2.2 Biologic Drugs: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Middle East and Africa Clinical Trials Supplies Market Analysis – by Application

10.1 Oncology

10.1.1 Overview
10.1.2 Oncology: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Cardiovascular Diseases

10.2.1 Overview
10.2.2 Cardiovascular Diseases: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.3 Neurological Disorders

10.3.1 Overview
10.3.2 Neurological Disorders: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.4 Respiratory Disorders

10.4.1 Overview
10.4.2 Respiratory Disorders: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. Middle East and Africa Clinical Trials Supplies Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East and Africa Clinical Trials Supplies Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 South Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.1.2 South Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.1.3 South Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.1.4 South Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Application

11.2.1.2 Saudi Arabia: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.2.2 Saudi Arabia: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.2.3 Saudi Arabia: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.2.4 Saudi Arabia: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Application

11.2.1.3 UAE: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 UAE: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.3.2 UAE: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.3.3 UAE: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.3.4 UAE: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Application

11.2.1.4 Rest of Middle East and Africa: Middle East and Africa Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.4.4 Rest of Middle East and Africa: Middle East and Africa Clinical Trials Supplies Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 UDG Healthcare plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Catalent Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 pci Pharma Services

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 PAREXEL INTERNATIONAL CORPORATION

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Biocair

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Owens & Minor Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East and Africa Clinical Trials Supplies Market